The Nitrosamine Challenge: How Canada and the US Are Tackling Impurity Testing in Pharmaceuticals
Ensuring the safety and efficacy of pharmaceuticals is a top priority for regulatory agencies and pharmaceutical companies worldwide. Among the […]
Collaborative Efforts in Nitrosamine Testing: How Canada and the US Are Working Together to Ensure Drug Safety
The presence of nitrosamine impurities in pharmaceuticals has raised global concerns regarding drug safety and regulatory compliance. Nitrosamines are classified
Nitrosamine Impurities Testing
Introduction: Nitrosamine Impurities Testing is the analytical process used to detect and quantify nitrosamine compounds—potentially carcinogenic impurities—in pharmaceutical products and
Nitrosamine Impurities Testing Read More »
Nitrosamine Impurities Testing
Introduction In recent years, the presence of nitrosamine impurities in pharmaceuticals has become a significant concern for regulatory agencies and
Nitrosamine Impurities Testing Read More »